These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25040545)

  • 1. Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Huang AM; Marini BL; Frame D; Aronoff DM; Nagel JL
    Transpl Infect Dis; 2014 Oct; 16(5):744-50. PubMed ID: 25040545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
    Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation.
    Chopra T; Chandrasekar P; Salimnia H; Heilbrun LK; Smith D; Alangaden GJ
    Clin Transplant; 2011; 25(1):E82-7. PubMed ID: 20973823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
    Alonso CD; Treadway SB; Hanna DB; Huff CA; Neofytos D; Carroll KC; Marr KA
    Clin Infect Dis; 2012 Apr; 54(8):1053-63. PubMed ID: 22412059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.
    Blumberg EA; Collins G; Young JH; Nguyen MH; Michonneau D; Temesgen Z; Origȕen J; Barcan L; Obeid KM; Belloso WH; Gras J; Corbelli GM; Neaton JD; Lundgren J; Snydman DR; Molina JM;
    Transpl Infect Dis; 2022 Feb; 24(1):e13770. PubMed ID: 34821423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare resource utilization and direct medical costs associated with index and recurrent
    Feuerstadt P; Stong L; Dahdal DN; Sacks N; Lang K; Nelson WW
    J Med Econ; 2020 Jun; 23(6):603-609. PubMed ID: 31999199
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
    Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
    Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and impact of Clostridium difficile recurrence on haematology patients.
    Scappaticci GB; Perissinotti AJ; Nagel JL; Bixby DL; Marini BL
    J Antimicrob Chemother; 2017 May; 72(5):1488-1495. PubMed ID: 28186243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic and Clinical Characteristics of Clostridioides difficile Infections in Hospitalized and Outpatient Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients.
    Barbar R; Hayden R; Sun Y; Tang L; Hakim H
    Pediatr Infect Dis J; 2021 Jul; 40(7):655-662. PubMed ID: 34097657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors.
    Alonso CD; Dufresne SF; Hanna DB; Labbé AC; Treadway SB; Neofytos D; Bélanger S; Huff CA; Laverdière M; Marr KA
    Biol Blood Marrow Transplant; 2013 Oct; 19(10):1502-8. PubMed ID: 23916741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study.
    Zilberberg MD; Reske K; Olsen M; Yan Y; Dubberke ER
    BMC Infect Dis; 2014 Jun; 14():306. PubMed ID: 24898123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.
    Kinnebrew MA; Lee YJ; Jenq RR; Lipuma L; Littmann ER; Gobourne A; No D; van den Brink M; Pamer EG; Taur Y
    PLoS One; 2014; 9(3):e90158. PubMed ID: 24662889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Observational Cohort Study of
    Rao K; Higgins PDR; Young VB
    mSphere; 2018; 3(3):. PubMed ID: 29794054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium Difficile Colonization in Hematopoietic Stem Cell Transplant Recipients: A Prospective Study of the Epidemiology and Outcomes Involving Toxigenic and Nontoxigenic Strains.
    Jain T; Croswell C; Urday-Cornejo V; Awali R; Cutright J; Salimnia H; Reddy Banavasi HV; Liubakka A; Lephart P; Chopra T; Revankar SG; Chandrasekar P; Alangaden G
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):157-63. PubMed ID: 26211988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
    Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP
    Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation.
    Weber S; Scheich S; Magh A; Wolf S; Enßle JC; Brunnberg U; Reinheimer C; Wichelhaus TA; Kempf VAJ; Kessel J; Vehreschild MJGT; Serve H; Bug G; Steffen B; Hogardt M
    Int J Infect Dis; 2020 Oct; 99():428-436. PubMed ID: 32798661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.
    Kamboj M; Xiao K; Kaltsas A; Huang YT; Sun J; Chung D; Wu S; Sheahan A; Sepkowitz K; Jakubowski AA; Papanicolaou G
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1626-33. PubMed ID: 24973628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care resource utilization and costs of recurrent
    Nelson WW; Scott TA; Boules M; Teigland C; Parente A; Unni S; Feuerstadt P
    J Manag Care Spec Pharm; 2021 Jul; 27(7):828-838. PubMed ID: 33703939
    [No Abstract]   [Full Text] [Related]  

  • 20. Utilization of Health Services Among Adults With Recurrent Clostridium difficile Infection: A 12-Year Population-Based Study.
    Kuntz JL; Baker JM; Kipnis P; Li SX; Liu V; Xie Y; Marcella S; Escobar GJ
    Infect Control Hosp Epidemiol; 2017 Jan; 38(1):45-52. PubMed ID: 27760583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.